We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EYEGW market cap is 192.23k. The company's latest EPS is USD -1.6966 and P/E is -1.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 16.01M | 20k | 996k |
| Operating Income | -5.92M | -2.12M | 13.22M | -2.53M | -3.71M |
| Net Income | -6.29M | -2.27M | 13.45M | -2.22M | -3.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.69M | 12k | 0 | 0 | 0 |
| Operating Income | -7.11M | -8.21M | -16.94M | -12.31M | -12.59M |
| Net Income | -7.1M | -8.09M | -16.4M | -13.58M | -13.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.9M | 13.71M | 42.44M | 40.81M | 38.51M |
| Total Liabilities | 7.79M | 7.6M | 7.54M | 7.71M | 8.48M |
| Total Equity | 8.1M | 6.11M | 34.9M | 33.1M | 30.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.11M | 15.16M | 18.06M | 18.68M | 13.71M |
| Total Liabilities | 3.49M | 8.16M | 8.83M | 7.27M | 7.6M |
| Total Equity | 6.62M | 7M | 9.23M | 11.41M | 6.11M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.98M | -9.56M | 13.63M | 9.89M | 10.81M |
| Investing | N/A | N/A | N/A | -21.23M | -23.15M |
| Financing | 6.45M | 5.97M | 15.25M | 15.5M | 15.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.15M | -7.32M | -10.89M | -10.43M | -9.56M |
| Investing | N/A | -244k | -157k | 6k | N/A |
| Financing | 3.92M | 5M | 17.8M | 8.62M | 5.97M |
| Market Cap | 192.23k |
| Price to Earnings Ratio | -1.92 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 10.21 |
| Price to Book Ratio | 4.1 |
| Dividend Yield | - |
| Shares Outstanding | 7.69M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.49 (98%) |
| Company Name | Eyegate Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://kiorapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
